{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:12:50Z","timestamp":1783339970453,"version":"3.54.6"},"reference-count":347,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.parkreldis.2006.06.002","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T13:19:47Z","timestamp":1153919987000},"page":"331-355","source":"Crossref","is-referenced-by-count":94,"title":["Botulinum toxin: Clinical use"],"prefix":"10.1016","volume":"12","author":[{"given":"Daniel D.","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2004-830901","article-title":"Botulism: update and review","volume":"24","author":"Cherington","year":"2004","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/jnnp.62.2.198","article-title":"Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases","volume":"62","author":"Bakheit","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1365-2133.2002.49101.x","article-title":"Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis","volume":"147","author":"Tugnoli","year":"2002","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.55.9.844","article-title":"Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system","volume":"55","author":"Girlanda","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib5","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib8","first-page":"459","article-title":"Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia","volume":"72","author":"Ranoux","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1","volume":"12","author":"Sampaio","year":"1997","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00702-004-0234-8","article-title":"Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers","volume":"112","author":"Jost","year":"2005","journal-title":"J Neural Transm"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","article-title":"Botulinum toxin type B for treatment of axillar hyperhidrosis","volume":"249","author":"Dressler","year":"2002","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group","volume":"246","author":"Kessler","year":"1999","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","article-title":"A pilot study on the use of botulinum toxin in spasmodic torticollis","volume":"12","author":"Tsui","year":"1985","journal-title":"Can J Neurol Sci"},{"issue":"8501","key":"10.1016\/j.parkreldis.2006.06.002_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"issue":"6648","key":"10.1016\/j.parkreldis.2006.06.002_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/bmj.297.6648.616","article-title":"Botulinum toxin treatment of spasmodic torticollis","volume":"297","author":"Stell","year":"1988","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40","author":"Greene","year":"1990","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.46.4.1066","article-title":"Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial","volume":"46","author":"Brans","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","article-title":"What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group","volume":"64","author":"Poewe","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov Disord"},{"issue":"Suppl","key":"10.1016\/j.parkreldis.2006.06.002_bib24","first-page":"A252","article-title":"Botulinum toxin type B compared with type A in the treatment of toxin-na\u00efve patients with cervical dystonia: results from a randomized, double-blind non-inferiority study","volume":"66","author":"Pappert","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1468-1331.2006.01440.x","article-title":"Treatment of cervical dystonia with botulinum toxins","volume":"13","author":"Comella","year":"2006","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.40.2.277","article-title":"Botulinum toxin injections for cervical dystonia","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib29","first-page":"91","article-title":"Dystonia\u2014a clinical, neuropathological and therapeutic review","volume":"38","author":"Wissel","year":"1992","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/PL00007848","article-title":"A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia","volume":"249","author":"Naumann","year":"2002","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014107689208500906","article-title":"Botulinum toxin treatment of spasmodic torticollis","volume":"85","author":"Anderson","year":"1992","journal-title":"J R Soc Med"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.53.8.633","article-title":"Botulinum toxin treatment of cranial\u2013cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm","volume":"53","author":"Jankovic","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib33","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/WNL.43.4.834","article-title":"Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia","volume":"43","author":"Jankovic","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period","volume":"17","author":"Hsiung","year":"2002","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.46.5.1213","article-title":"Blepharospasm: report of a workshop","volume":"46","author":"Hallett","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib37","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial\u2013cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib38","first-page":"24","article-title":"Treatment of blepharospasm with medication, surgery and type A botulinum toxin","volume":"22","author":"Arthurs","year":"1987","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bjo.71.9.664","article-title":"Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections","volume":"71","author":"Elston","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib40","unstructured":"Truong D. Randomized controlled trial of botulinum type A toxin complex (Dysport) for the treatment of benign essential blepharospasm. In: World congress of neurology, Sydney, 2005, p. 903."},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"Nussgens","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00007813","article-title":"Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm","volume":"248","author":"Jost","year":"2001","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01676830490506041","article-title":"Impact on quality of life of botulinum toxin treatments for essential blepharospasm","volume":"23","author":"MacAndie","year":"2004","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.2004.00357.x","article-title":"Health-related quality of life in blepharospasm or hemifacial spasm","volume":"111","author":"Reimer","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0404.2001.00109.x","article-title":"Quality of life in patients with blepharospasm","volume":"103","author":"Tucha","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenkamper","year":"2006","journal-title":"J Neural Transm"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib47","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum A toxin in the treatment of blepharospasm","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1442-9071.1994.tb00793.x","article-title":"Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm","volume":"22","author":"Price","year":"1994","journal-title":"Aust NZ J Ophthalmol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib49","first-page":"67","article-title":"A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin","volume":"13","author":"Price","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib50","first-page":"133","article-title":"Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study","volume":"26","author":"Taylor","year":"1991","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: a review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib52","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1531-8257(199911)14:6<1017::AID-MDS1018>3.0.CO;2-3","article-title":"Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial","volume":"14","author":"Mezaki","year":"1999","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00005537-199704000-00007","article-title":"Pitfalls in the diagnosis of hemifacial spasm","volume":"107","author":"Zappia","year":"1997","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","article-title":"Treatment of hemifacial spasm with botulinum toxin","volume":"15","author":"Yoshimura","year":"1992","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","article-title":"Botulinum a toxin treatment of hemifacial spasm and blepharospasm","volume":"8","author":"Park","year":"1993","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2006.06.002_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2004.01.010","article-title":"Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30)","volume":"219","author":"Tan","year":"2004","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.49.7.827","article-title":"Botulinum toxin treatment of hemifacial spasm","volume":"49","author":"Elston","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib59","first-page":"285","article-title":"Botulinum toxin A in clinical medicine","volume":"84","author":"Elston","year":"1990","journal-title":"J Physiol (Paris)"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","article-title":"Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases","volume":"64","author":"Jitpimolmard","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/PL00007849","article-title":"Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"249","author":"Cakmur","year":"2002","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2273.1996.tb01018.x","article-title":"Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy","volume":"21","author":"Armstrong","year":"1996","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archotol.127.4.389","article-title":"Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia","volume":"127","author":"Bhattacharyya","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000348948909800202","article-title":"Botulinum toxin injection for the treatment of oromandibular dystonia","volume":"98","author":"Blitzer","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib65","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1288\/00005537-199111000-00010","article-title":"Treatment of oromandibular dystonia with botulinum toxin","volume":"101","author":"Hermanowicz","year":"1991","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib66","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/WNL.53.9.2102","article-title":"Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up","volume":"53","author":"Tan","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13","author":"Bhidayasiri","year":"2006","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib68","first-page":"205","article-title":"Botulinum toxin A in blepharospasm and hemifacial spasm","volume":"42","author":"Behari","year":"1994","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02340723","article-title":"Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group","volume":"14","author":"Berardelli","year":"1993","journal-title":"Ital J Neurol Sci"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib70","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1055\/s-2001-19572","article-title":"Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin","volume":"80","author":"Laskawi","year":"2001","journal-title":"Laryngorhinootologie"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib71","first-page":"245","article-title":"Use of botulinum toxin in Meige's disease","volume":"58","author":"Maurri","year":"1988","journal-title":"Riv Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib72","first-page":"1","article-title":"Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients","volume":"80","author":"Poungvarin","year":"1997","journal-title":"J Med Assoc Thai"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib74","series-title":"Therapy with botulinum toxin","first-page":"429","article-title":"Oromandibular dystonia: treatment of 96 patients with botulinum toxin type A","author":"Brin","year":"1994"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib75","first-page":"44","article-title":"Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms","volume":"20","author":"Wan","year":"2005","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib76","series-title":"Diseases of workers translated from De Morbis Artificum Diatriba of 1713","author":"Ramazzini","year":"1964"},{"issue":"9463","key":"10.1016\/j.parkreldis.2006.06.002_bib77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(05)71080-1","article-title":"Ramazzini and writer's cramp","volume":"365","author":"Altschuler","year":"2005","journal-title":"Lancet"},{"issue":"351","key":"10.1016\/j.parkreldis.2006.06.002_bib78","first-page":"4","article-title":"Clinical lectures on scriveners\u2019 palsy, or the paralysis of writers. 1864","author":"Solly","year":"1998","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1212\/WNL.44.1.70","article-title":"Long-term botulinum toxin treatment of focal hand dystonia","volume":"44","author":"Karp","year":"1994","journal-title":"Neurology"},{"issue":"Suppl 8","key":"10.1016\/j.parkreldis.2006.06.002_bib80","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/mds.20025","article-title":"Botulinum toxin treatment of occupational and focal hand dystonia","volume":"19","author":"Karp","year":"2004","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jnnp.52.3.355","article-title":"Treatment of focal dystonias of the hand with botulinum toxin injections","volume":"52","author":"Cohen","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00839202","article-title":"Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin","volume":"239","author":"Lees","year":"1992","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib83","first-page":"239","article-title":"Writer's cramp: the experience with botulinum toxin injections in 25 patients","volume":"74","author":"Poungvarin","year":"1991","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002826-199619040-00004","article-title":"Botulinum toxin in the treatment of writer's cramp","volume":"19","author":"Turjanski","year":"1996","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jnnp.61.2.172","article-title":"Botulinum toxin in writer's cramp: objective response evaluation in 31 patients","volume":"61","author":"Wissel","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib86","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/jnnp.2003.032227","article-title":"Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin","volume":"75","author":"Djebbari","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.43.1_Part_1.183","article-title":"Botulinum toxin in the treatment of writer's cramp: a double-blind study","volume":"43","author":"Tsui","year":"1993","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1468-1331.2006.01446.x","article-title":"Botulinum toxin therapy of writer's cramp","volume":"13","author":"Das","year":"2006","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib89","first-page":"694","article-title":"Botulinum toxin in the treatment of writer's cramp","volume":"47","author":"Behari","year":"1999","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib90","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/01.WNL.0000149768.36634.92","article-title":"Botulinum toxin injections in the treatment of musician's dystonia","volume":"64","author":"Schuele","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mds.10647","article-title":"Long-term outcome of focal dystonia in string instrumentalists","volume":"19","author":"Schuele","year":"2004","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00887828","article-title":"Isolated idiopathic adult-onset foot dystonia and treatment with botulinum toxin","volume":"242","author":"Duarte","year":"1995","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2005.07.004","article-title":"Adult-onset primary focal foot dystonia","volume":"12","author":"Singer","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib94","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.870110405","article-title":"Treatment of nonoccupational limb and trunk dystonia with botulinum toxin","volume":"11","author":"Quirk","year":"1996","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-510X(97)00186-X","article-title":"Delayed segmental axial dystonia of the trunk on standing after lumbar disk operation","volume":"152","author":"Ghika","year":"1997","journal-title":"J Neurol Sci"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib97","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/jnnp.57.12.1535","article-title":"Optimisation of botulinum treatment for cervical and axial dystonias: experience with a Japanese type A toxin","volume":"57","author":"Mezaki","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib98","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.870130330","article-title":"Extensor truncal dystonia: successful treatment with botulinum toxin injections","volume":"13","author":"Comella","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib99","series-title":"Tardive dyskinesias","author":"Fahn","year":"1984"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib100","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/WNL.32.12.1335","article-title":"Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs","volume":"32","author":"Burke","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib101","first-page":"415","article-title":"Tardive dystonia","volume":"50","author":"Kang","year":"1988","journal-title":"Adv Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib102","first-page":"438","article-title":"Botulinum toxin in treatment of tardive dyskinetic syndrome","volume":"10","author":"Truong","year":"1990","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib103","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.41.7.1088","article-title":"Cervical dystonia: clinical findings and associated movement disorders","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1192\/bjp.161.6.867","article-title":"Botulinum toxin in a case of severe tardive dyskinesia mixed with dystonia","volume":"161","author":"Stip","year":"1992","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/jnp.6.1.50","article-title":"Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia","volume":"6","author":"Kaufman","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib106","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jnnp.58.4.511","article-title":"Successful treatment of intractable tardive dyskinesia with botulinum toxin","volume":"58","author":"Yasufuku-Takano","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib107","first-page":"844","article-title":"Improvement of both tardive dystonia and akathisia after botulinum toxin injection","volume":"46","author":"Shulman","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib108","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00002826-199702000-00012","article-title":"An open-label study of botulinum toxin A for treatment of tardive dystonia","volume":"20","author":"Tarsy","year":"1997","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib109","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1531-8257(199909)14:5<886::AID-MDS1034>3.0.CO;2-W","article-title":"Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect","volume":"14","author":"Kanovsky","year":"1999","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00873549","article-title":"Laryngeal tardive dyskinesia","volume":"242","author":"Feve","year":"1995","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.870110413","article-title":"Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome","volume":"11","author":"Scott","year":"1996","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib112","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.870130348","article-title":"Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections","volume":"13","author":"Trimble","year":"1998","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib113","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mds.870110627","article-title":"Botulinum toxin for refractory vocal tics","volume":"11","author":"Salloway","year":"1996","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib114","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mds.870110512","article-title":"Severe motor tics causing cervical myelopathy in Tourette's syndrome","volume":"11","author":"Krauss","year":"1996","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.870090315","article-title":"Botulinum toxin in the treatment of dystonic tics","volume":"9","author":"Jankovic","year":"1994","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib116","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","article-title":"Botulinum toxin in the treatment of tics","volume":"57","author":"Kwak","year":"2000","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib117","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","article-title":"Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A","volume":"24","author":"Porta","year":"2004","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib118","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S0317167100052240","article-title":"Head tremor in cervical dystonia","volume":"27","author":"Pal","year":"2000","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mds.870120516","article-title":"Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor","volume":"12","author":"Wissel","year":"1997","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib121","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/WNL.41.8.1185","article-title":"Botulinum toxin treatment of tremors","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000117196","article-title":"Botulinum toxin A in non-dystonic tremors","volume":"36","author":"Henderson","year":"1996","journal-title":"Eur Neurol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib123","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib124","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin A injections for the treatment of hand tremors","volume":"9","author":"Trosch","year":"1994","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib125","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib126","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.41.10.1677","article-title":"Ear click in palatal tremor: its origin and treatment with botulinum toxin","volume":"41","author":"Deuschl","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib127","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.46.4.1168","article-title":"Ear clicks in palatal tremor caused by activity of the levator veli palatini","volume":"46","author":"Jamieson","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib128","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.45.4.712","article-title":"Botulinum toxin A for spasticity, muscle spasms, and rigidity","volume":"45","author":"Grazko","year":"1995","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1469-8749.2002.tb00268.x","article-title":"Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study","volume":"44","author":"Baker","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib131","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib132","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/apmr.2003.50070","article-title":"Treatment with botulinum toxin type B for upper-limb spasticity","volume":"84","author":"Brashear","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib134","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp.61.3.265","article-title":"A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients","volume":"61","author":"Burbaud","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib136","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib137","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0012162206000041","article-title":"Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Mall","year":"2006","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib138","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10072-005-0378-9","article-title":"A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot","volume":"26","author":"Mancini","year":"2005","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib139","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","article-title":"A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury","volume":"14","author":"Smith","year":"2000","journal-title":"Clin Rehabil"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib141","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410280407","article-title":"Treatment of spasticity with botulinum toxin: a double-blind study","volume":"28","author":"Snow","year":"1990","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib143","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1191\/0269215505cr827oa","article-title":"A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury","volume":"19","author":"Verplancke","year":"2005","journal-title":"Clin Rehabil"},{"issue":"Suppl 5","key":"10.1016\/j.parkreldis.2006.06.002_bib144","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1468-1331.2001.00052.x","article-title":"Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation","volume":"8","author":"Houltram","year":"2001","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/16501970510027312","article-title":"Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity","volume":"37","author":"Ward","year":"2005","journal-title":"J Rehabil Med"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib146","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00002060-199811000-00012","article-title":"Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial","volume":"77","author":"Kirazli","year":"1998","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib147","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib148","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib149","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3928\/0191-3913-19840501-06","article-title":"Botulinum toxin chemo-denervation for strabismus in infants and children","volume":"21","author":"Magoon","year":"1984","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00140912","article-title":"Injection treatment of endocrine orbital myopathy","volume":"58","author":"Scott","year":"1984","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib151","first-page":"405","article-title":"A review of 5 years\u2019 experience in the use of botulinium toxin A in the treatment of sixth cranial nerve palsy at the Singapore National Eye Centre","volume":"40","author":"Quah","year":"1999","journal-title":"Singapore Med J"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib152","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9394(02)02092-5","article-title":"Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure","volume":"135","author":"Kikkawa","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2008-1034938","article-title":"[Protective ptosis by botulinum A toxin injection in corneal affectations]","volume":"213","author":"Gusek-Schneider","year":"1998","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib154","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1442-9071.2001.d01-28.x","article-title":"An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis","volume":"29","author":"Ellis","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp.65.1.111","article-title":"Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy","volume":"65","author":"Boroojerdi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib156","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bjo.86.1.43","article-title":"Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation","volume":"86","author":"Keegan","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib157","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.eye.6700230","article-title":"Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland","volume":"16","author":"Montoya","year":"2002","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib158","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/S0161-6420(99)90534-1","article-title":"Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report","volume":"106","author":"Riemann","year":"1999","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib159","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002341-200007000-00007","article-title":"Treatment of Frey's syndrome (gustatory sweating) and \u2018crocodile tears\u2019 (gustatory epiphora) with purified botulinum toxin","volume":"16","author":"Hofmann","year":"2000","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib160","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.joms.2003.09.015","article-title":"The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes","volume":"62","author":"Kyrmizakis","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib161","first-page":"1300","article-title":"Botulinum toxin (BOTOX) for the treatment of \u201cspastic dysphonia\u201d as part of a trial of toxin injections for the treatment of other cranial dystonias","volume":"96","author":"Blitzer","year":"1986","journal-title":"Laryngoscope"},{"issue":"6 Part 1","key":"10.1016\/j.parkreldis.2006.06.002_bib162","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1288\/00005537-199106000-00010","article-title":"Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia","volume":"101","author":"Troung","year":"1991","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib163","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1044\/1092-4388(2002\/037)","article-title":"Botox treatment in adductor spasmodic dysphonia: a meta-analysis","volume":"45","author":"Boutsen","year":"2002","journal-title":"J Speech Lang Hear Res"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib164","first-page":"CD004327","article-title":"Botulinum toxin injections for the treatment of spasmodic dysphonia","author":"Watts","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"10.1016\/j.parkreldis.2006.06.002_bib165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/13682829809179445","article-title":"Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies","volume":"33","author":"Whurr","year":"1998","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib166","first-page":"237","article-title":"Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin","volume":"78","author":"Brin","year":"1998","journal-title":"Adv Neurol"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib167","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00005537-199810000-00003","article-title":"Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients","volume":"108","author":"Blitzer","year":"1998","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib168","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archotol.1987.01860060029009","article-title":"Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report","volume":"113","author":"Miller","year":"1987","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5 Part 1","key":"10.1016\/j.parkreldis.2006.06.002_bib169","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/019459989010300515","article-title":"Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia","volume":"103","author":"Ford","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0194-5998(94)70569-0","article-title":"Technique for injection of botulinum toxin through the flexible nasolaryngoscope","volume":"111","author":"Rhew","year":"1994","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib171","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/000348949210101101","article-title":"Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia","volume":"101","author":"Green","year":"1992","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib172","first-page":"196","article-title":"Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach","volume":"21","author":"Garcia Ruiz","year":"1998","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib173","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.38.8.1220","article-title":"Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia","volume":"38","author":"Ludlow","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib174","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.53.6.530","article-title":"Treatment of bruxism with botulinum toxin injections","volume":"53","author":"Van Zandijcke","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14219\/jada.archive.2000.0149","article-title":"Treating severe bruxism with botulinum toxin","volume":"131","author":"Tan","year":"2000","journal-title":"J Am Dent Assoc"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib176","first-page":"566","article-title":"Rhinorrhea is decreased in dogs after nasal application of botulinum toxin","volume":"112","author":"Shaari","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib177","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S0022215100158281","article-title":"The effect of botulinum toxin type A injection for intrinsic rhinitis","volume":"112","author":"Kim","year":"1998","journal-title":"J Laryngol Otol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib178","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000055778","article-title":"Minimally invasive application of botulinum toxin type A in nasal hypersecretion","volume":"63","author":"Rohrbach","year":"2001","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib179","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/00016489.2003.11720744","article-title":"Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial","volume":"123","author":"Unal","year":"2003","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/joms.2003.50086","article-title":"Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies","volume":"61","author":"Ellies","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib181","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","article-title":"Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis","volume":"69","author":"Giess","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","author":"Lagalla","year":"2006","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib183","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib184","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib185","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.10484","article-title":"Botulinum toxin B reduces sialorrhea in parkinsonism","volume":"18","author":"Racette","year":"2003","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib186","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib187","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2006.06.002_bib188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.04.017","article-title":"Expanding use of botulinum toxin","volume":"235","author":"Bhidayasiri","year":"2005","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib189","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2002-37084","article-title":"Successful management of drooling with botulinum toxin A in neurologically disabled children","volume":"33","author":"Ellies","year":"2002","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib191","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005537-200201000-00014","article-title":"Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy","volume":"112","author":"Suskind","year":"2002","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib192","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib193","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1531-8257(199911)14:6<1057::AID-MDS1033>3.0.CO;2-4","article-title":"Treatment of drooling in Parkinson's disease with botulinum toxin","volume":"14","author":"Jost","year":"1999","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2006.06.002_bib194","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(01)00565-2","article-title":"Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis","volume":"190","author":"Tan","year":"2001","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.70.3.417","article-title":"Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach","volume":"70","author":"Winterholler","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib196","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0887-8994(02)00381-8","article-title":"Botulinum toxin A as a treatment for excessive drooling in children","volume":"27","author":"Bothwell","year":"2002","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib197","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib198","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2018blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib199","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1076-0512(98)00189-7","article-title":"Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin","volume":"24","author":"Carruthers","year":"1998","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines","volume":"51","author":"Ascher","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib201","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C. botulinum-A exotoxin","volume":"18","author":"Carruthers","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib203","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00006534-199407000-00009","article-title":"Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study","volume":"94","author":"Keen","year":"1994","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib204","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","article-title":"Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet","volume":"47","author":"Lowe","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1524-4725.2003.29132.x","article-title":"A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial","volume":"29","author":"Baumann","year":"2003","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib206","first-page":"1089","article-title":"Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines","volume":"112","author":"Carruthers","year":"2003","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib207","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1524-4725.2005.31107","article-title":"Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib208","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1076-0512(98)00179-4","article-title":"Botulinum A toxin for glabellar wrinkles. Dose and response","volume":"24","author":"Hankins","year":"1998","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib209","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006534-199902000-00043","article-title":"Botulinum A exotoxin for the management of platysma bands","volume":"103","author":"Matarasso","year":"1999","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1524-4725.2002.01116.x","article-title":"Botulinum toxin A: successful decollete rejuvenation","volume":"28","author":"Becker-Wegerich","year":"2002","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib211","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006534-199404001-00003","article-title":"Aesthetic indications for botulinum toxin injection","volume":"93","author":"Guyuron","year":"1994","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib212","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0161-6420(96)30644-1","article-title":"The use of botulinum A toxin to ameliorate facial kinetic frown lines","volume":"103","author":"Foster","year":"1996","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archotol.1997.01900030103013","article-title":"Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection","volume":"123","author":"Pribitkin","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib214","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archoto.123.4.389","article-title":"The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients","volume":"123","author":"Blitzer","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0190-9622(96)90682-9","article-title":"Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique","volume":"35","author":"Lowe","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib216","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1524-4725.2003.29114.x","article-title":"A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides","volume":"29","author":"Carruthers","year":"2003","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib217","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-2004-817724","article-title":"Disorders of sweating","volume":"23","author":"Cheshire","year":"2003","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib218","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clindermatol.2003.12.029","article-title":"Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis","volume":"22","author":"Kreyden","year":"2004","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib219","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2004.07.030","article-title":"Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin","volume":"51","author":"Swartling","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"7313","key":"10.1016\/j.parkreldis.2006.06.002_bib220","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib221","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1365-2133.2002.05059.x","article-title":"Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial","volume":"147","author":"Naumann","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib222","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2133.1997.tb02139.x","article-title":"Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms","volume":"136","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib223","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.134.3.301","article-title":"Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin","volume":"134","author":"Naumann","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib224","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1365-2133.1998.2576k.x","article-title":"Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application","volume":"139","author":"Naumann","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0003-9993(98)90020-X","article-title":"Axillary hyperhidrosis: treatment with botulinum toxin A","volume":"79","author":"Odderson","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib226","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2133.1999.02769.x","article-title":"A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis","volume":"140","author":"Schnider","year":"1999","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.parkreldis.2006.06.002_bib227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0190-9622(98)70242-7","article-title":"Botulinum toxin therapy for palmar hyperhidrosis","volume":"38","author":"Shelley","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib228","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archneur.56.8.914","article-title":"Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system","volume":"56","author":"Naumann","year":"1999","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib229","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1076-0512(98)00077-6","article-title":"Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib230","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1111\/j.1468-1331.1999.tb00028.x","article-title":"Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years\u2019 experience","volume":"6","author":"Naver","year":"1999","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib231","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1468-1331.2000.00014.x","article-title":"Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up","volume":"7","author":"Naver","year":"2000","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib232","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0190-9622(99)70258-6","article-title":"Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis","volume":"41","author":"Heckmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib233","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib234","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0190-9622(00)90298-6","article-title":"Botulinum toxin type A therapy for palmar and digital hyperhidrosis","volume":"42","author":"Solomon","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib235","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archderm.136.4.487","article-title":"Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase","volume":"136","author":"Karamfilov","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib236","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-1331.2001.00207.x","article-title":"Botulinum A toxin improves life quality in severe primary focal hyperhidrosis","volume":"8","author":"Swartling","year":"2001","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib237","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2133.2004.06250.x","article-title":"BOTOX delivery by iontophoresis","volume":"151","author":"Kavanagh","year":"2004","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib238","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.141.10.1255","article-title":"Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study","volume":"141","author":"Heckmann","year":"2005","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib239","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.2004.06255.x","article-title":"No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis","volume":"152","author":"Krogstad","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2004.08.024","article-title":"Treatment of facial chromhidrosis with botulinum toxin type A","volume":"52","author":"Matarasso","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib241","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archderm.139.2.226","article-title":"Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis","volume":"139","author":"Baumann","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib242","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clindermatol.2003.11.001","article-title":"Botulinum toxin-B and the management of hyperhidrosis","volume":"22","author":"Baumann","year":"2004","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib243","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","article-title":"A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis","volume":"149","author":"Simonetta Moreau","year":"2003","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib244","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00016489509139348","article-title":"Frey's syndrome: treatment with botulinum toxin","volume":"115","author":"Drobik","year":"1995","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib245","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005537-199803000-00013","article-title":"Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome)","volume":"108","author":"Laskawi","year":"1998","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib246","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.410420619","article-title":"Treatment of gustatory sweating with botulinum toxin","volume":"42","author":"Naumann","year":"1997","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib247","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1790::AID-MUS26>3.0.CO;2-I","article-title":"Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxin","volume":"21","author":"Bergmann","year":"1998","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib248","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1468-3083.2002.00361.x","article-title":"Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left\u2013right comparison","volume":"16","author":"Wollina","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib249","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mjd.2002.124605","article-title":"Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin","volume":"47","author":"Swartling","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib250","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.57.11.2095","article-title":"Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study","volume":"57","author":"Saadia","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib251","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1468-3083.2001.00350.x","article-title":"Botulinum toxin A for palmar hyperhidrosis","volume":"15","author":"Wollina","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib252","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-4632.2004.02304.x","article-title":"Treatment of plantar hyperhidrosis with botulinum toxin type A","volume":"43","author":"Vadoud-Seyedi","year":"2004","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib253","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archderm.139.6.731","article-title":"Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study","volume":"139","author":"Naumann","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib254","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1524-4725.2002.01252.x","article-title":"Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis","volume":"28","author":"Odderson","year":"2002","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1067\/mjd.2002.118341","article-title":"High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval","volume":"46","author":"Wollina","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib256","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib257","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archotol.125.3.283","article-title":"Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome","volume":"125","author":"Laccourreye","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib258","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.0007-1323.2001.01982.x","article-title":"Botulinum toxin A in the treatment of patients with Frey syndrome","volume":"89","author":"Beerens","year":"2002","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib259","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0022215100138769","article-title":"Frey's syndrome: treatment with botulinum toxin","volume":"111","author":"Bjerkhoel","year":"1997","journal-title":"J Laryngol Otol"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib260","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s004150070073","article-title":"Botulinum toxin for treatment of craniofacial hyperhidrosis","volume":"247","author":"Boger","year":"2000","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib261","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1524-4725.2005.31071","article-title":"Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis","volume":"31","author":"Baumann","year":"2005","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib262","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1523-1747.2003.12620.x","article-title":"Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up","volume":"121","author":"Birklein","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib263","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib264","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib266","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib267","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0003-9993(03)00202-8","article-title":"Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report","volume":"84","author":"Dykstra","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"2 Part 1","key":"10.1016\/j.parkreldis.2006.06.002_bib268","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib269","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib270","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib271","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"issue":"2 Part 1","key":"10.1016\/j.parkreldis.2006.06.002_bib272","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib273","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib274","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","article-title":"Therapeutic effects of suburothelial injection of botulinum A toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions","volume":"67","author":"Kuo","year":"2006","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib276","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib277","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib278","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib279","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jnnp.63.4.474","article-title":"Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections","volume":"63","author":"Schurch","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 8","key":"10.1016\/j.parkreldis.2006.06.002_bib280","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/mds.20068","article-title":"Botulinum toxin in neuro-urological disorders","volume":"19","author":"Jost","year":"2004","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib281","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib282","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","article-title":"Prostate botulinum A toxin injection\u2014an alternative treatment for benign prostatic obstruction in poor surgical candidates","volume":"65","author":"Kuo","year":"2005","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib283","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"9047","key":"10.1016\/j.parkreldis.2006.06.002_bib284","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(05)64862-3","article-title":"Treatment of vaginismus with botulinum toxin injections","volume":"349","author":"Brin","year":"1997","journal-title":"Lancet"},{"issue":"5 Part 1","key":"10.1016\/j.parkreldis.2006.06.002_bib285","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/01.AOG.0000141441.41178.6b","article-title":"Botulinum toxin in the treatment of refractory vaginismus","volume":"104","author":"Ghazizadeh","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.parkreldis.2006.06.002_bib286","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM199503233321203","article-title":"Intrasphincteric botulinum toxin for the treatment of achalasia","volume":"332","author":"Pasricha","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib287","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0016-5085(96)70002-1","article-title":"Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia","volume":"111","author":"Annese","year":"1996","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib288","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-1999-56","article-title":"Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation","volume":"31","author":"Muehldorfer","year":"1999","journal-title":"Endoscopy"},{"issue":"3\u20134","key":"10.1016\/j.parkreldis.2006.06.002_bib289","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1442-2050.2001.00189.x","article-title":"Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia","volume":"14","author":"Ghoshal","year":"2001","journal-title":"Dis Esophagus"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib290","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1572-0241.2002.05821.x","article-title":"Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction","volume":"97","author":"Miller","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib291","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/BF02093606","article-title":"Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter","volume":"41","author":"Miller","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib292","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00005537-200007000-00016","article-title":"Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction","volume":"110","author":"Alberty","year":"2000","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib293","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000348949410300105","article-title":"Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method","volume":"103","author":"Schneider","year":"1994","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"10.1016\/j.parkreldis.2006.06.002_bib294","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/gut.35.9.1319","article-title":"Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction","volume":"35","author":"Pasricha","year":"1994","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.parkreldis.2006.06.002_bib295","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1046\/j.1365-2036.2000.00814.x","article-title":"Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction","volume":"14","author":"Wehrmann","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib296","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2036.2006.02773.x","article-title":"Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study","volume":"23","author":"Gui","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib297","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1067\/mge.2002.124739","article-title":"Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis","volume":"55","author":"Ezzeddine","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib298","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1572-0241.2002.05823.x","article-title":"Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle","volume":"97","author":"Miller","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib299","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00384-002-0398-3","article-title":"Ten years\u2019 experience with botulin toxin in anal fissure","volume":"17","author":"Jost","year":"2002","journal-title":"Int J Colorectal Dis"},{"issue":"Suppl 8","key":"10.1016\/j.parkreldis.2006.06.002_bib300","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/mds.20070","article-title":"Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms","volume":"19","author":"Brisinda","year":"2004","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2003.01598.x","article-title":"Review article: botulinum toxin in the therapy of gastrointestinal motility disorders","volume":"18","author":"Gui","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib302","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF02081409","article-title":"Initial North American experience with botulinum toxin type A for treatment of anismus","volume":"39","author":"Joo","year":"1996","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib303","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02258305","article-title":"Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome","volume":"43","author":"Maria","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib304","first-page":"218","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles","volume":"105","author":"Ishikawa","year":"2001","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"issue":"1 Part 2","key":"10.1016\/j.parkreldis.2006.06.002_bib306","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1523\/JNEUROSCI.15-01-00520.1995","article-title":"Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions","volume":"15","author":"Sala","year":"1995","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib307","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(90)90001-7","article-title":"Neuropeptide Y co-exists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic, and internal carotid ganglia of the rat","volume":"36","author":"Suzuki","year":"1990","journal-title":"Neuroscience"},{"issue":"31","key":"10.1016\/j.parkreldis.2006.06.002_bib308","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1021\/bi010362z","article-title":"Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process","volume":"40","author":"Puffer","year":"2001","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.parkreldis.2006.06.002_bib309","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib311","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.bjp.0704162","article-title":"The anti-migraine 5-HT(1B\/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs","volume":"133","author":"Williamson","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib312","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00019052-200006000-00009","article-title":"Tension-type headache: an update on mechanisms and treatment","volume":"13","author":"Jensen","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib313","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-230X-2-19","article-title":"Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment","volume":"2","author":"Storr","year":"2002","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib314","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1468-2982.1994.1405320.x","article-title":"Neuropeptides in migraine and cluster headache","volume":"14","author":"Edvinsson","year":"1994","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib315","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.56.10.1290","article-title":"Botulinum toxin A and chronic low back pain: a randomized, double-blind study","volume":"56","author":"Foster","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib316","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","article-title":"Botulinum toxin in the treatment of myofascial pain syndrome","volume":"59","author":"Cheshire","year":"1994","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib317","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.PHM.0000113404.35647.D8","article-title":"Botulinum toxin type B in piriformis syndrome","volume":"83","author":"Lang","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"issue":"3 Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib318","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1053\/apmr.2003.50121","article-title":"Botulinum toxin type A therapy in chronic pain disorders","volume":"84","author":"Lang","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib319","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1526-4610.1994.hed3408458.x","article-title":"Tension headache: botulinum toxin paralysis of temporal muscles","volume":"34","author":"Zwart","year":"1994","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11916-000-0007-5","article-title":"A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache","volume":"4","author":"Porta","year":"2000","journal-title":"Curr Rev Pain"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib321","first-page":"I12","article-title":"Botulinum toxin in tension-type headache","volume":"251","author":"Relja","year":"2004","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib322","first-page":"183","article-title":"Treatment of tension-type headache with botulinum toxin: a pilot study","volume":"4","author":"Schulte-Mattler","year":"1999","journal-title":"Eur J Med Res"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2006.06.002_bib323","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib324","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","article-title":"Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial","volume":"41","author":"Schmitt","year":"2001","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib325","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","article-title":"Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study","volume":"40","author":"Rollnik","year":"2000","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib326","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1468-2982.2004.00738.x","article-title":"Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial","volume":"24","author":"Padberg","year":"2004","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.parkreldis.2006.06.002_bib327","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2006.06.002_bib328","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1468-1331.2006.01445.x","article-title":"Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations","volume":"13","author":"Schulte-Mattler","year":"2006","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib329","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1468-2982.2004.00754.x","article-title":"Botulinum toxin A in the prophylactic treatment of migraine\u2014a randomized, double-blind, placebo-controlled study","volume":"24","author":"Evers","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib330","first-page":"702","article-title":"Botulinum toxin A in the prophylactic treatment of migraine\u2014a randomized, double-blind, placebo-controlled study","volume":"23","author":"Schwaag","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib331","first-page":"421","article-title":"Botox for migraine: double-blind, placebo-controlled, region-specific evaluation [abstract]","volume":"20","author":"Brin","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib332","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10194-003-0049-2","article-title":"Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study","volume":"4","author":"Barrientos","year":"2003","journal-title":"J Headache Pain"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib333","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1526-4610.2003.03163.x","article-title":"Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders","volume":"43","author":"Blumenfeld","year":"2003","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib334","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","article-title":"Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial","volume":"45","author":"Mathew","year":"2005","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib335","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4610.2005.05068.x","article-title":"Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study","volume":"45","author":"Dodick","year":"2005","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib336","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-2982.2004.00641.x","article-title":"Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study","volume":"24","author":"Ondo","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.parkreldis.2006.06.002_bib337","first-page":"577","article-title":"Double-blind, placebo-controlled study of Myobloc (botulinum toxin type B) for the treatment of chronic headache","volume":"43","author":"Gwynn","year":"2003","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib338","first-page":"213","article-title":"A study of salivary secretion in Parkinson's disease","volume":"22","author":"Bagheri","year":"1999","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"10.1016\/j.parkreldis.2006.06.002_bib339","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","article-title":"Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment","volume":"22","author":"Cadeddu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib340","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004150170134","article-title":"The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study","volume":"248","author":"Giladi","year":"2001","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.parkreldis.2006.06.002_bib341","first-page":"CR282","article-title":"Botulinum toxin type B for gait freezing in Parkinson's disease","volume":"10","author":"Fernandez","year":"2004","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.parkreldis.2006.06.002_bib342","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/01.wnl.0000172930.63669.c8","article-title":"Botulinum toxin injections do not improve freezing of gait in Parkinson disease","volume":"65","author":"Wieler","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2006.06.002_bib343","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.arth.2004.11.008","article-title":"Flexion contracture after total knee arthroplasty in a patient with Parkinson's disease: successful treatment with botulinum toxin type A","volume":"20","author":"Shah","year":"2005","journal-title":"J Arthroplasty"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib344","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2005.07.012","article-title":"Lower limb post-immobilization dystonia in Parkinson's disease","volume":"239","author":"Singer","year":"2005","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.parkreldis.2006.06.002_bib345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1048-891x.2004.014021.x","article-title":"Unique use of botulinum toxin to decrease adductor tone and allow surgical excision of vulvar carcinoma","volume":"14","author":"Guo","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.parkreldis.2006.06.002_bib346","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.1186","article-title":"Treatment of dystonic clenched fist with botulinum toxin","volume":"16","author":"Cordivari","year":"2001","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2006.06.002_bib347","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/01.wnl.0000171857.09079.9f","article-title":"Camptocormia: pathogenesis, classification, and response to therapy","volume":"65","author":"Azher","year":"2005","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:38:42Z","timestamp":1707147522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802006001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":347,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1353802006001416"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2006.06.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}